Related ACE Reports
- Published: Mar 2017
- ACE Report #9574
AAOS2017: Local steroid following ACDF lowers incidence of dysphagia postoperatively
Study Type: Randomized Trial
OE Level of Evidence: N/A
Journal Level of Evidence: N/A
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Why was this study needed now?
Two of the most common complications following anterior cervical discectomy and fusion (ACDF) are dysphagia and dysphonia. While these complications are often mild and transient, some cases are severe and can have detrimental effects on the overall health of patients. Several studies have indicated that local steroids can reduce prevertebral soft tissue swelling following ACDF, but none have evaluated the effect of local steroid injections on dysphagia and dysphonia compared to a control.
What was the principal research question?
Following anterior cervical discectomy and fusion, does local or intravenous steroid administration have any significant effect on outcome measures related to dysphagia and dysphonia in comparison to no steroid when assessed over the first 6 weeks postoperatively?
|Population:||72 patients, over the age of 18 years, with cervical degenerative disc disease and scheduled for anterior cervical discectomy and fusion.|
|Intervention:||IV steroid group: Patients received a single intraoperative dose of 10mg intravenous dexamethasone. (n=25) Local steroid group: Patients received 40mg of triamcinolone in the retropharyngeal space directly on the cervical plate. (n=29)|
|Comparison:||Control group: Patients did not receive steroid administration (n=19)|
|Outcomes:||The primary outcomes were dysphagia (Bazaz, Eat-10) and dysphonia (VHI-10). Secondary outcomes included Neck Disability Index (NDI) and pain on a visual analgoue scale (VAS).|
|Time:||Outcomes were assessed on day 1, week 2, and week 6|
What were the important findings?
What should I remember most?
How will this affect the care of my patients?
The authors responsible for this critical appraisal and ACE Report indicate no potential conflicts of interest relating to the content in the original publication.